Showing results (11-20 of 180) with videos related to
Sort By:
Pageof 18
Cancer Treatment Reports|November 1, 1978
Suppressor cell activity in cancer patients: a possible role for thymic hormonesY Z Patt, E M Hersh, K Dicke, et al.Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1985
Arterial infusion of dacarbazine and cisplatin for recurrent regionally confined melanomaD B Frost, Y Z Patt, G Mavligit, et al.Annals of Surgical Oncology|September 1, 1996
Colorectal carcinoma and brain metastasis: distribution, treatment, and survivalM A Hammoud, I E McCutcheon, R Elsouki, et al.The American Journal of Medicine|August 1, 1983
Effective retreatment of patients with colorectal cancer and liver metastasesY Z Patt, R E Peters, V P Chuang, et al.AJR. American Journal of Roentgenology|August 1, 1981
Hepatic artery infusion chemotherapy: gastroduodenal complicationsV P Chuang, S Wallace, J Stroehlein, et al.Cancer|May 1, 1988
Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liverY Z Patt, L Claghorn, C Charnsangavej, et al.Cancer|February 15, 1993
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinomaR Pazdur, J A Ajani, Y Z Patt, et al.Postgraduate Medicine|May 1, 1980
Superficial head and neck metastases in adults with widespread cancerS Dreizen, K B McCredie, G P Bodey, et al.Investigational New Drugs|February 1, 1993
Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinomaJ A Ajani, J L Abbruzzese, A B Markowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastasesA Y Bedikian, T T Chen, M A Malahy, et al.Pageof 18